Kathrin Schramm

Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling

Marc Zuckermann, Volker Hovestadt, Christiane B. Knobbe‐Thomsen et al. · Nature Communications · 2015 · 301 citations · Full text

Life Sciences, Genetics, Oncology +12

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets

Cornelis M. van Tilburg, Elke Pfaff, Kristian W. Pajtler et al. · Cancer Discovery · 2021 · 260 citations · Full text

Medicine, Oncology, Pediatrics +13

Genomic ALK alterations in primary and relapsed neuroblastoma

Carolina Rosswog, Jana Fassunke, Angela Ernst et al. · British Journal of Cancer · 2023 · 66 citations · Full text

Medicine, Oncology, Pathology +17

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

Heike Peterziel, Nora Jamaladdin, Dina ElHarouni et al. · npj Precision Oncology · 2022 · 62 citations · Full text

Medicine, Oncology, Pharmacology +14

Nuclear Calcium Buffering Capacity Shapes Neuronal Architecture

Daniela Mauceri, Anna M. Hagenston, Kathrin Schramm et al. · Journal of Biological Chemistry · 2015 · 42 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17